Details for Patent: 9,657,021

Which drugs does patent 9,657,021 protect, and when does it expire?

Patent 9,657,021 protects ZAYNICH and is included in one NDA.

This patent has sixteen patent family members in ten countries.

Summary for Patent: 9,657,021

Title:	Process for preparation of (2S, 5R)-7-oxo-6-sulphooxy-2[((3R)-piperidine-3-carbonyl)-hydrazino carbonyl]-1,6-diaza-bicyclo [3.2.1]-octane
Abstract:	A process for preparation of (2S,5R)-7-oxo-6-sulphooxy-2-[((3R)-piperidine-3-carbonyl)-hydrazino carbonyl]-1,6-diaza-bicyclo[3.2.1]octane of Formula (I) is disclosed which is comprising reacting a compound of Formula (II) with a compound of Formula (III) to obtain a compound of Formula (IV). Crystalline compounds of Formula (I) are claimed.
Inventor(s):	Sanjeev Joshi, Karuna Suresh WANKHEDE, Sunil Bhaginath Jadhav, Shivaji Sampatrao Pawar, Vinod Kashinath AHIRRAO, Satish Bhawsar, Prasad Keshav Deshpande, Ravindra Dattatraya Yeole, Mahesh Vithalbhai Patel
Assignee:	Wockhardt Ltd
Application Number:	US14/769,815
Patent Claim Types: see list of patent claims	Use; Compound; Process;

error: insufficient information

Drugs Protected by US Patent 9,657,021

Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	TE	Type	RLD	RS	Patent No.	Patent Expiration	Product	Substance	Delist Req.	Patented / Exclusive Use	Submissiondate
Wockhardt Bio Ag	ZAYNICH	cefepime hydrochloride; zidebactam	POWDER;INTRAVENOUS	220787-001	May 29, 2026		RX	Yes	Yes				Y

International Family Members for US Patent 9,657,021

Country	Patent Number	Estimated Expiration	Supplementary Protection Certificate	SPC Country	SPC Expiration
Australia	2013380574
Brazil	112015021393
Canada	2904079